E. G. Malayeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
E. G. Malayeva has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Igor O. Stoma
Gomel State Medical University
9 shared publications - I. L. Mamchenko
Gomel State Medical University
5 shared publications - O. V. Osipkina
Gomel State Medical University
5 shared publications - Evgenii Voropaev
Gomel State Medical University
4 shared publications - Kovalev Aliaksei Aliakseevich
Gomel State Medical University
4 shared publications - A. E. Karpenka
Gomel State Medical University
2 shared publications
Latest Publications
- Open Access
- 5 August 2026
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 23 (2) , 36-46
Clinical and microbiological characteristics of urinary tract infections in liver cirrhosis
Objective. Analysis of the prevalence, clinical features, and microbiological data of urinary tract infections (UTI) in patients with liver cirrhosis (LC). Materials and methods. A prospective observational study was conducted on 338 hospitalized patients with liver cirrhosis aged 55.00 (45.00; 63.00) years old, including 189 (55.92%) men and 149 (44.08%) women, with class A – 78 (23.08%), class B – 118 (34.91%), and class C – 142 (42.01%) patients. The study included a microbiological examination of 1,056 urine samples for microbiota and antibiotic sensitivity over a 48-hour period from admission to the hospital organization and after 48 hours of hospitalization. Statistical data processing was performed in the R programming environment. The significance level α is taken to be 0.05. The study was registered in Clinicaltrials.gov (NCT05335213). Results. The incidence of urinary tract infections is 37.87%, and asymptomatic bacteriuria is 23.96% in hospitalized patients with liver cirrhosis. Urinary tract infections are more commonly diagnosed in women (57.81% vs. 42.19%, pConclusion. Urinary tract infections in hospitalized patients with liver cirrhosis have a high prevalence, in most cases have a complicated course, are health-care associated, are associated with an unfavorable prognosis, are characterized by a polymicrobial spectrum of pathogens that belongs to the Pseudomonadota and Bacillota department. The choice of antibacterial drugs should be based on local resistance and be optimized based on the results of drug sensitivity.
- 5 August 2026
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 23 (2) , 36-46
Open AccessClinical and microbiological characteristics of urinary tract infections in liver cirrhosis
Objective. Analysis of the prevalence, clinical features, and microbiological data of urinary tract infections (UTI) in patients with liver cirrhosis (LC). Materials and methods. A prospective observational study was conducted on 338 hospitalized patients with liver cirrhosis aged 55.00 (45.00; 63.00) years old, including 189 (55.92%) men and 149 (44.08%) women, with class A – 78 (23.08%), class B – 118 (34.91%), and class C – 142 (42.01%) patients. The study included a microbiological examination of 1,056 urine samples for microbiota and antibiotic sensitivity over a 48-hour period from admission to the hospital organization and after 48 hours of hospitalization. Statistical data processing was performed in the R programming environment. The significance level α is taken to be 0.05. The study was registered in Clinicaltrials.gov (NCT05335213). Results. The incidence of urinary tract infections is 37.87%, and asymptomatic bacteriuria is 23.96% in hospitalized patients with liver cirrhosis. Urinary tract infections are more commonly diagnosed in women (57.81% vs. 42.19%, pConclusion. Urinary tract infections in hospitalized patients with liver cirrhosis have a high prevalence, in most cases have a complicated course, are health-care associated, are associated with an unfavorable prognosis, are characterized by a polymicrobial spectrum of pathogens that belongs to the Pseudomonadota and Bacillota department. The choice of antibacterial drugs should be based on local resistance and be optimized based on the results of drug sensitivity.
- 1 July 2026
- Published by Grodno State Medical University in Journal of the Grodno State Medical University
- Vol. 24 (3)
DIFFERENTIAL DIAGNOSIS OF ASYMPTOMATIC BACTERIURIA AND URINARY TRACT INFECTIONS IN LIVER CIRRHOSIS
In clinical practice, it is necessary to strictly distinguish between groups of patients with asymptomatic bacteriuria (ABU) and urinary tract infection (UTI) based on standard and additional criteria, as well as to determine absolute indications for the use of antibacterial drugs in order to prevent their side effects and development of antimicrobial resistance. Objective. To perform a differential diagnosis of ABU and UTI in patients with liver cirrhosis (LC) based on blood and urine laboratory data. Material and methods. A prospective observational study was conducted on 338 hospitalized patients with LC aged 55.00 (45.00; 63.00) years, including 189 (55.92%) men and 149 (44.08%) women. The patients were classified as class A – 78 (23.08%), class B – 118 (34.91%), and class C – 142 (42.01%) individuals. The study included standard research methods in accordance with the Clinical Protocol as well as the determination of lactoferrin, Kidney Injury Molecule 1 (KIM-1), Neutrophil Gelatinase Associated Lipocalin (NGAL) in urine, homocysteine, and lipopolysaccharide-binding protein (LBP) in blood. The study was registered in Clinicaltrials.gov (NCT05335213). Results. In hospitalized patients with LC, the incidence of UTIs was 37.87%, and that of ABU – 23.96%. The levels of bilirubin, leukocytes, erythrocyte sedimentation rate, C-reactive protein (CRP), blood ferritin, total protein, urinary lactoferrin, NGAL, and KIM-1 in patients with LC and UTI were significantly higher, while the levels of blood albumin, hemoglobin and prothrombin index (PTI) were lower compared to those with ABU (p<0.05). When conducting differential diagnosis between ABU and UTIs in patients with LC, additional criteria for UTI may be: blood leukocyte level ≥8.6×109/l (diagnostic efficacy (DE) – 75.08%, AUC=0.759), CRP ≥12.45 mg/l (DE – 72.19%, AUC=0.718), albumin ≤28.35 g/l (DE – 73.11%, AUC=0.776), PTI <0.69 (DE – 71.29%, AUC=0.758), and urinary NGAL ≥38.27 ng/ml (DE – 68.74%, AUC=0.723). Conclusion. The differential diagnosis between ABU and UTIs includes a comprehensive approach based on the analysis of characteristic clinical symptoms, instrumental and microbiological data, as well as additional laboratory biomarkers.
- 1 July 2026
- Published by Grodno State Medical University in Journal of the Grodno State Medical University
- Vol. 24 (3)
DIFFERENTIAL DIAGNOSIS OF ASYMPTOMATIC BACTERIURIA AND URINARY TRACT INFECTIONS IN LIVER CIRRHOSIS
In clinical practice, it is necessary to strictly distinguish between groups of patients with asymptomatic bacteriuria (ABU) and urinary tract infection (UTI) based on standard and additional criteria, as well as to determine absolute indications for the use of antibacterial drugs in order to prevent their side effects and development of antimicrobial resistance. Objective. To perform a differential diagnosis of ABU and UTI in patients with liver cirrhosis (LC) based on blood and urine laboratory data. Material and methods. A prospective observational study was conducted on 338 hospitalized patients with LC aged 55.00 (45.00; 63.00) years, including 189 (55.92%) men and 149 (44.08%) women. The patients were classified as class A – 78 (23.08%), class B – 118 (34.91%), and class C – 142 (42.01%) individuals. The study included standard research methods in accordance with the Clinical Protocol as well as the determination of lactoferrin, Kidney Injury Molecule 1 (KIM-1), Neutrophil Gelatinase Associated Lipocalin (NGAL) in urine, homocysteine, and lipopolysaccharide-binding protein (LBP) in blood. The study was registered in Clinicaltrials.gov (NCT05335213). Results. In hospitalized patients with LC, the incidence of UTIs was 37.87%, and that of ABU – 23.96%. The levels of bilirubin, leukocytes, erythrocyte sedimentation rate, C-reactive protein (CRP), blood ferritin, total protein, urinary lactoferrin, NGAL, and KIM-1 in patients with LC and UTI were significantly higher, while the levels of blood albumin, hemoglobin and prothrombin index (PTI) were lower compared to those with ABU (p<0.05). When conducting differential diagnosis between ABU and UTIs in patients with LC, additional criteria for UTI may be: blood leukocyte level ≥8.6×109/l (diagnostic efficacy (DE) – 75.08%, AUC=0.759), CRP ≥12.45 mg/l (DE – 72.19%, AUC=0.718), albumin ≤28.35 g/l (DE – 73.11%, AUC=0.776), PTI <0.69 (DE – 71.29%, AUC=0.758), and urinary NGAL ≥38.27 ng/ml (DE – 68.74%, AUC=0.723). Conclusion. The differential diagnosis between ABU and UTIs includes a comprehensive approach based on the analysis of characteristic clinical symptoms, instrumental and microbiological data, as well as additional laboratory biomarkers.
- 17 May 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 104 (3)
Gut microbiota and urobiota in liver cirrhosis with urinary tract infections
The purpose of the study was to examine the differences and commonality of the gut microbiota and urobiota in patients with liver cirrhosis (LC), depending on the presence of urinary tract infections (UTI). Material and methods. A prospective cohort study was conducted on 125 patients with LC, including 41 — without UTI, 22 — with asymptomatic bacteriuria (ABU), and 62 — with UTI. The results and their discussion . The beta diversity of the gut microbiota and urobiota differs in LC without UTI, with ABU, and with UTI (p = 0.002 and p = 0.001). In the gut microbiota in LC without UTI — with ABU — with UTI, there is an increase in the abundance of Pseudomonadota taxa (1.25 [0.49; 3.15]% — 5.76 [1.34; 10.29]% — 6.40 [1.78; 31.23]%, p = 0.0003), Gammaproteobacteria (0.57 [0.05; 2.59]% — 4.06 [0.63; 7.16]% — 4.47 [0.9; 29.82]%, p = 0.0004), Bacilli (2.52 [1.28; 7.96]% — 6.75 [2.51; 15.91]% — 13.86 [3.5; 26.52]%, p = 0.006) and decreased Bacteroidota density (42.94 [31.77; 67.78]% without UTI, 25.38 [0.95; 44.58]% with UTI, p = 0.003). Urobiota in LC without UTI — with ABU — with UTI are characterized by an increase in Pseudomonadota taxa (68.48 [38.7; 90.69]% — 71,57 [20,3; 88,4]% — 80.51 [8.85; 93.07]%, p = 0.029), Gammaproteobacteria (33.59 [26.5; 48.95]% — 38.95 [14.08; 78.94]% — 52.8 [5.25; 86.88]%, p = 0.004) and a decrease in Actinomycetota (2.89 [1.24; 5.59]% — 1.63 [0.22; 4.08]% — 0.5 [0.08; 3.8]%, р = 0.03), Clostridia (0.94 [0.07; 2.36]% — 0.4 [0.06; 5.98]% — 0.24 [0.03; 0.93]%, p = 0.011). The commonality between the urobiota and the gut microbiota in patients with LC with UTI ranges from 96% at the department level to 61.5% at the species level. Conclusion. In patients with LC with UTI, there is a change in the beta diversity of the gut microbiota and urobiota, an increase in the abundance of pathogenic taxa (Pseudomonadota, Gammaproteobacteria, Bacilli), and a decrease in the abundance of commensal taxa (Bacteroidota, Actinomycetota, Clostridia) compared to the group without UTI.
- 17 May 2026
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 104 (3)
Gut microbiota and urobiota in liver cirrhosis with urinary tract infections
The purpose of the study was to examine the differences and commonality of the gut microbiota and urobiota in patients with liver cirrhosis (LC), depending on the presence of urinary tract infections (UTI). Material and methods. A prospective cohort study was conducted on 125 patients with LC, including 41 — without UTI, 22 — with asymptomatic bacteriuria (ABU), and 62 — with UTI. The results and their discussion . The beta diversity of the gut microbiota and urobiota differs in LC without UTI, with ABU, and with UTI (p = 0.002 and p = 0.001). In the gut microbiota in LC without UTI — with ABU — with UTI, there is an increase in the abundance of Pseudomonadota taxa (1.25 [0.49; 3.15]% — 5.76 [1.34; 10.29]% — 6.40 [1.78; 31.23]%, p = 0.0003), Gammaproteobacteria (0.57 [0.05; 2.59]% — 4.06 [0.63; 7.16]% — 4.47 [0.9; 29.82]%, p = 0.0004), Bacilli (2.52 [1.28; 7.96]% — 6.75 [2.51; 15.91]% — 13.86 [3.5; 26.52]%, p = 0.006) and decreased Bacteroidota density (42.94 [31.77; 67.78]% without UTI, 25.38 [0.95; 44.58]% with UTI, p = 0.003). Urobiota in LC without UTI — with ABU — with UTI are characterized by an increase in Pseudomonadota taxa (68.48 [38.7; 90.69]% — 71,57 [20,3; 88,4]% — 80.51 [8.85; 93.07]%, p = 0.029), Gammaproteobacteria (33.59 [26.5; 48.95]% — 38.95 [14.08; 78.94]% — 52.8 [5.25; 86.88]%, p = 0.004) and a decrease in Actinomycetota (2.89 [1.24; 5.59]% — 1.63 [0.22; 4.08]% — 0.5 [0.08; 3.8]%, р = 0.03), Clostridia (0.94 [0.07; 2.36]% — 0.4 [0.06; 5.98]% — 0.24 [0.03; 0.93]%, p = 0.011). The commonality between the urobiota and the gut microbiota in patients with LC with UTI ranges from 96% at the department level to 61.5% at the species level. Conclusion. In patients with LC with UTI, there is a change in the beta diversity of the gut microbiota and urobiota, an increase in the abundance of pathogenic taxa (Pseudomonadota, Gammaproteobacteria, Bacilli), and a decrease in the abundance of commensal taxa (Bacteroidota, Actinomycetota, Clostridia) compared to the group without UTI.
- Open Access
- 16 April 2026
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 23 (1) , 35-42
Spontaneous pneumothorax: features of its occurrence and course in patients treated over a three-year period in a thoracic surgery department
Objective . To consider currently known theories of spontaneous pneumothorax (SP). To study gender and age structure of the SP patient group, and to identify common patterns in the course of SP among patients in Gomel and the Gomel region. Materials and methods . Literary data on the genesis of SP were analyzed. A retrospective analysis of 226 medical records of hospital patients treated for SP at the surgical thoracic department of the Gomel Regional Clinical Hospital in the period 2019–2021 was conducted. A comparative assessment of patients’ social, anthropometric, epidemiological, and clinical data was conducted. The obtained data were processed in the STATISTICA 10.0 software package using descriptive statistics. Results . The gender and age distribution of patients with SP was determined. Males with an average age of 36,1 (95% CI 34.2 – 38.0, SD=14.6) in a formed group predominated (79.6%). It was found out that patients with primary spontaneous pneumothorax (PSP) were more common than secondary spontaneous pneumothorax (88% and 12%, respectively). Patients with a normal body mass index (BMI) predominated in the group, median value complied 20,4±3,2 kg/m². Other constitutional features important for determining the dysplastic phenotype could not be clarified within the retrospective study. The vast majority of patients had no precursors or trigger factors for the development of SP. Individual patients noted lifting weights the day before the onset of SP (n=11), training in the gym with strength exercises the day before SP or long-distance running (n=7), as well as presence of acute respiratory disease in a medical history (n 19) among the provoking factors. The majority of patients had right-sided SP (n=176; 77.9%) with the rupture localized in the S1-S2 segments. Macroscopic and microscopic histological material is shown signs of the bullous emphysema in 198 (87,6%) cases. Conclusion . This study analyzes existing working hypotheses regarding the causes of SP. Gender and age structure of the patients with SP in the case of 226 patients treated at hospitals over a three-year period. PSP was more frequently diagnosed in young men in the study group that corresponds to published data. The frequency of occurrence and nosological forms of secondary SP were identified, among which chronic obstructive pulmonary disease predominated; secondary SP was significantly more common in elderly patients. The right-sided localization of the process with damage to the apical segments of the lungs prevailed. Multiple bullae that were not detected on X-ray images of the lungs were revealed in the vast majority of patients during the histological examination of lung tissue resected during surgical intervention. The volume of SP prior to surgical treatment amounted to a half of normal. Analysis of medical records revealed a lack of data for evaluation of the dysplastic phenotype of the patients according to the current criteria. A prospective study is needed for a detailed and comprehensive study of the role of connective tissue dysplasia in the development of SP, as well as the presence of histological markers indicating connective tissue dysfunction and fibrosis.
- 16 April 2026
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 23 (1) , 35-42
Open AccessSpontaneous pneumothorax: features of its occurrence and course in patients treated over a three-year period in a thoracic surgery department
Objective . To consider currently known theories of spontaneous pneumothorax (SP). To study gender and age structure of the SP patient group, and to identify common patterns in the course of SP among patients in Gomel and the Gomel region. Materials and methods . Literary data on the genesis of SP were analyzed. A retrospective analysis of 226 medical records of hospital patients treated for SP at the surgical thoracic department of the Gomel Regional Clinical Hospital in the period 2019–2021 was conducted. A comparative assessment of patients’ social, anthropometric, epidemiological, and clinical data was conducted. The obtained data were processed in the STATISTICA 10.0 software package using descriptive statistics. Results . The gender and age distribution of patients with SP was determined. Males with an average age of 36,1 (95% CI 34.2 – 38.0, SD=14.6) in a formed group predominated (79.6%). It was found out that patients with primary spontaneous pneumothorax (PSP) were more common than secondary spontaneous pneumothorax (88% and 12%, respectively). Patients with a normal body mass index (BMI) predominated in the group, median value complied 20,4±3,2 kg/m². Other constitutional features important for determining the dysplastic phenotype could not be clarified within the retrospective study. The vast majority of patients had no precursors or trigger factors for the development of SP. Individual patients noted lifting weights the day before the onset of SP (n=11), training in the gym with strength exercises the day before SP or long-distance running (n=7), as well as presence of acute respiratory disease in a medical history (n 19) among the provoking factors. The majority of patients had right-sided SP (n=176; 77.9%) with the rupture localized in the S1-S2 segments. Macroscopic and microscopic histological material is shown signs of the bullous emphysema in 198 (87,6%) cases. Conclusion . This study analyzes existing working hypotheses regarding the causes of SP. Gender and age structure of the patients with SP in the case of 226 patients treated at hospitals over a three-year period. PSP was more frequently diagnosed in young men in the study group that corresponds to published data. The frequency of occurrence and nosological forms of secondary SP were identified, among which chronic obstructive pulmonary disease predominated; secondary SP was significantly more common in elderly patients. The right-sided localization of the process with damage to the apical segments of the lungs prevailed. Multiple bullae that were not detected on X-ray images of the lungs were revealed in the vast majority of patients during the histological examination of lung tissue resected during surgical intervention. The volume of SP prior to surgical treatment amounted to a half of normal. Analysis of medical records revealed a lack of data for evaluation of the dysplastic phenotype of the patients according to the current criteria. A prospective study is needed for a detailed and comprehensive study of the role of connective tissue dysplasia in the development of SP, as well as the presence of histological markers indicating connective tissue dysfunction and fibrosis.
- 1 January 2026
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 10 (1)
Urinary tract infections in liver cirrhosis
Introduction. Bacterial infections are a common pathology in patients with liver cirrhosis (LC) among which urinary tract infections (UTIs) are widely spread. Aim. To study the incidence, features of the course, risk factors of UTIs in hospitalized patients with LC, and the disease prognosis depending on the presence of UTIs. Materials and methods. A prospective observational study involving 338 hospitalized patients with LC aged 30 to 84 years (median, 55,00 (45,00; 63,00) years), 189 (55,92%) men and 149 (44,08%) women was conducted. Child-Pugh class A liver cirrhosis was diagnosed in 78 (23,08%) patients, class B – in 118 (34,91%), class C – in 142 (42,01%). Bacterial infections were detected in 172 (50,89%) patients with LC. Clinical examination, clinical investigations and laboratory tests, urine culture with antimicrobial susceptibility testing using conventional microbiological methods were performed in all the patients. Results. In patients with LC, the incidence of UTIs was 37,87%, and the incidence of asymptomatic bacteriuria – 23,96%. UTIs were more common in women with LC (female to male ratio was 57,81% vs. 42,19%, p < 0,001), in patients with decompensated LC (p < 0,001), and in those with LC duration of less than 5 years (p = 0,016). UTIs co-existed with other infections in 45,31% of cases. In patients with LC, UTIs with systemic manifestations (79,69%), with anatomical and structural changes of the urinary tract according to imaging studies (79%), healthcare-associated infections (44,53%), catheter-associated infections (56,25%), and infections with risk factors (RFs) (94,5%), including more than one RF in 75% of cases, predominated. Among the patients with LC and UTIs 70% died within 45 months of follow-up, which was significantly higher compared to patients without UTIs – 34% (p < 0,001). Conclusion. The high incidence of UTIs in hospitalized patients with LC, the complicated course with the presence of RFs, systemic inflammatory response, co-infections, and the association with an unfavorable prognosis of the disease indicate the need for their timely diagnosis and medical prevention.
- 1 January 2026
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 10 (1)
Urinary tract infections in liver cirrhosis
Introduction. Bacterial infections are a common pathology in patients with liver cirrhosis (LC) among which urinary tract infections (UTIs) are widely spread. Aim. To study the incidence, features of the course, risk factors of UTIs in hospitalized patients with LC, and the disease prognosis depending on the presence of UTIs. Materials and methods. A prospective observational study involving 338 hospitalized patients with LC aged 30 to 84 years (median, 55,00 (45,00; 63,00) years), 189 (55,92%) men and 149 (44,08%) women was conducted. Child-Pugh class A liver cirrhosis was diagnosed in 78 (23,08%) patients, class B – in 118 (34,91%), class C – in 142 (42,01%). Bacterial infections were detected in 172 (50,89%) patients with LC. Clinical examination, clinical investigations and laboratory tests, urine culture with antimicrobial susceptibility testing using conventional microbiological methods were performed in all the patients. Results. In patients with LC, the incidence of UTIs was 37,87%, and the incidence of asymptomatic bacteriuria – 23,96%. UTIs were more common in women with LC (female to male ratio was 57,81% vs. 42,19%, p < 0,001), in patients with decompensated LC (p < 0,001), and in those with LC duration of less than 5 years (p = 0,016). UTIs co-existed with other infections in 45,31% of cases. In patients with LC, UTIs with systemic manifestations (79,69%), with anatomical and structural changes of the urinary tract according to imaging studies (79%), healthcare-associated infections (44,53%), catheter-associated infections (56,25%), and infections with risk factors (RFs) (94,5%), including more than one RF in 75% of cases, predominated. Among the patients with LC and UTIs 70% died within 45 months of follow-up, which was significantly higher compared to patients without UTIs – 34% (p < 0,001). Conclusion. The high incidence of UTIs in hospitalized patients with LC, the complicated course with the presence of RFs, systemic inflammatory response, co-infections, and the association with an unfavorable prognosis of the disease indicate the need for their timely diagnosis and medical prevention.
- Open Access
- 27 September 2025
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 22 (3) , 7-14
Cardiorenal syndrome: issues of pathogenesis and diagnosis
The combined disorders in a human’s body related to functioning of such vital organs as heart and kidney with development and progress of concomitant hemodynamic disorders is called as cardiorenal syndrome. In early studies, insufficient cardiac pump function with subsequent renal dysfunction was considered as the main pathophysiologic component of cardiorenal syndrome. At the current stage of studying this syndrome, there is a greater understanding of the mechanisms of its development, however, there are also insufficiently studied aspects, since multiple systems of the human body can influence its occurrence and course. This review aims to analyze scientific publications covering the studied etiological factors, pathophysiological mechanisms, and pathogenesis of type 2 cardiorenal syndrome, as well as current issues in diagnosis and treatment of chronic kidney disease associated with chronic heart failure. The objective of the review is to analyze current data on pathogenetic mechanisms, diagnostic approaches and treatment strategies for type 2 cardiorenal syndrome, focusing on novel biomarkers and therapeutic methods. The literature review was conducted according to: Systematic analysis of publications in international databases (PubMed, Scopus, Web of Science). Priority to clinical guidelines and meta-analyses. Critical evaluation of evidence base. Emphasis on studies with clear diagnostic criteria of type 2 cardiorenal syndrome. Inclusion of both fundamental and clinical research The analysis covers publications from 2018-2023, including some seminal earlier works that have fundamental importance for understanding of pathogenesis. Special attention was given to studies conducted for the period of 2020-2023 and reflecting modern diagnostic and therapeutic advances.
- 27 September 2025
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 22 (3) , 7-14
Open AccessCardiorenal syndrome: issues of pathogenesis and diagnosis
The combined disorders in a human’s body related to functioning of such vital organs as heart and kidney with development and progress of concomitant hemodynamic disorders is called as cardiorenal syndrome. In early studies, insufficient cardiac pump function with subsequent renal dysfunction was considered as the main pathophysiologic component of cardiorenal syndrome. At the current stage of studying this syndrome, there is a greater understanding of the mechanisms of its development, however, there are also insufficiently studied aspects, since multiple systems of the human body can influence its occurrence and course. This review aims to analyze scientific publications covering the studied etiological factors, pathophysiological mechanisms, and pathogenesis of type 2 cardiorenal syndrome, as well as current issues in diagnosis and treatment of chronic kidney disease associated with chronic heart failure. The objective of the review is to analyze current data on pathogenetic mechanisms, diagnostic approaches and treatment strategies for type 2 cardiorenal syndrome, focusing on novel biomarkers and therapeutic methods. The literature review was conducted according to: Systematic analysis of publications in international databases (PubMed, Scopus, Web of Science). Priority to clinical guidelines and meta-analyses. Critical evaluation of evidence base. Emphasis on studies with clear diagnostic criteria of type 2 cardiorenal syndrome. Inclusion of both fundamental and clinical research The analysis covers publications from 2018-2023, including some seminal earlier works that have fundamental importance for understanding of pathogenesis. Special attention was given to studies conducted for the period of 2020-2023 and reflecting modern diagnostic and therapeutic advances.
- Open Access
- 29 March 2025
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 22 (1) , 127-136
Atypical clinical case of ankylosing spondylitis
Objective. To demonstrate a clinical case of atypical ankylosing spondylitis.Materials and methods. Retrospective analysis of the medical history of a patient hospitalized in the Rheumatology Department of Gomel City Clinical Hospital No. 1.Results. Ankylosing spondylitis is one of the most difficult to diagnose causes of specific pain in the lower back. The medical and social significance of the disease lies in a high level of disability of young people, and in a decrease in the quality of patients’ life. There are no specific diagnostic markers of spondylitis at an early stage of the disease. The reasons for the late diagnosis of the disease are the untimely arrival of patients for medical help, the asymptomatic course of ankylosing spondylitis, and insufficient knowledge of the diagnostic criteria of the disease by doctors.The article presents a clinical case of atypical ankylosing spondylitis in a young patient with no signs of systemic inflammation and classic manifestations of the disease.Conclusion. Targeted examination of the lumbosacral spine and sacroiliac joints should be recommended for patients with pain in the lower back in order to verify ankylosing spondylitis.
- 29 March 2025
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 22 (1) , 127-136
Open AccessAtypical clinical case of ankylosing spondylitis
Objective. To demonstrate a clinical case of atypical ankylosing spondylitis.Materials and methods. Retrospective analysis of the medical history of a patient hospitalized in the Rheumatology Department of Gomel City Clinical Hospital No. 1.Results. Ankylosing spondylitis is one of the most difficult to diagnose causes of specific pain in the lower back. The medical and social significance of the disease lies in a high level of disability of young people, and in a decrease in the quality of patients’ life. There are no specific diagnostic markers of spondylitis at an early stage of the disease. The reasons for the late diagnosis of the disease are the untimely arrival of patients for medical help, the asymptomatic course of ankylosing spondylitis, and insufficient knowledge of the diagnostic criteria of the disease by doctors.The article presents a clinical case of atypical ankylosing spondylitis in a young patient with no signs of systemic inflammation and classic manifestations of the disease.Conclusion. Targeted examination of the lumbosacral spine and sacroiliac joints should be recommended for patients with pain in the lower back in order to verify ankylosing spondylitis.
- Open Access
- 29 March 2025
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 22 (1) , 23-31
Microbiota of ascitic fluid and other biotopes in liver cirrhosis: a pilot study
Objective. To determine the composition of the microbiota of ascitic fluid in patients with liver cirrhosis and compare it with the intestinal microbiota and urobiota.Materials and methods. A cross-sectional single-center study was conducted for 5 hospitalized patients with decompensated liver cirrhosis with ascites who, along with standard research methods, underwent metagenomic sequencing of ascitic fluid, urine and feces. High-throughput sequencing was performed using a MiSeq genetic analyzer (Illumina, USA) using a protocol based on the analysis of variable regions of the 16s rRNA gene. The assignment of taxonomic levels and quantitative assessment of the microbiome composition were performed using the Kraken 2 program (PlusPF database dated 06/05/2024). The study is registered in Clinicaltrials.gov (NCT05335213).Results. A unique composition of the ascitic fluid microbiota represented by 29 types, 35 classes, 67 orders, 129 families, 231 genera, and 266 bacterial species has been determined in patients with liver cirrhosis with ascites in the absence of spontaneous bacterial peritonitis. The Pseudomonadota is the dominant type (95,4% [94,8; 95,9]), the Gammaproteobacteria is the dominant class (47,7% [45,9; 48,4]), the Stenotrophomonas is the dominant genera (47,6% [46,2; 48,0]) in the microbiota of ascitic fluid.For the first time it has been shown that the similarity of the microbiota of ascitic fluid and urobiota is 68,3%, microbiota of ascitic fluid and gut – 69,0% at the type level.Conclusion. The study examined the microbiota of ascitic fluid in patients with liver cirrhosis using metagenomic sequencing. Despite the negative results of cultural research methods, it has been shown that ascitic fluid is not a sterile medium and contains a large number of microorganisms, which in most cases have commonalities with the microbiota of the gut and urinary tract.
- 29 March 2025
- Published by Gomel State Medical University in Health and Ecology Issues
- Vol. 22 (1) , 23-31
Open AccessMicrobiota of ascitic fluid and other biotopes in liver cirrhosis: a pilot study
Objective. To determine the composition of the microbiota of ascitic fluid in patients with liver cirrhosis and compare it with the intestinal microbiota and urobiota.Materials and methods. A cross-sectional single-center study was conducted for 5 hospitalized patients with decompensated liver cirrhosis with ascites who, along with standard research methods, underwent metagenomic sequencing of ascitic fluid, urine and feces. High-throughput sequencing was performed using a MiSeq genetic analyzer (Illumina, USA) using a protocol based on the analysis of variable regions of the 16s rRNA gene. The assignment of taxonomic levels and quantitative assessment of the microbiome composition were performed using the Kraken 2 program (PlusPF database dated 06/05/2024). The study is registered in Clinicaltrials.gov (NCT05335213).Results. A unique composition of the ascitic fluid microbiota represented by 29 types, 35 classes, 67 orders, 129 families, 231 genera, and 266 bacterial species has been determined in patients with liver cirrhosis with ascites in the absence of spontaneous bacterial peritonitis. The Pseudomonadota is the dominant type (95,4% [94,8; 95,9]), the Gammaproteobacteria is the dominant class (47,7% [45,9; 48,4]), the Stenotrophomonas is the dominant genera (47,6% [46,2; 48,0]) in the microbiota of ascitic fluid.For the first time it has been shown that the similarity of the microbiota of ascitic fluid and urobiota is 68,3%, microbiota of ascitic fluid and gut – 69,0% at the type level.Conclusion. The study examined the microbiota of ascitic fluid in patients with liver cirrhosis using metagenomic sequencing. Despite the negative results of cultural research methods, it has been shown that ascitic fluid is not a sterile medium and contains a large number of microorganisms, which in most cases have commonalities with the microbiota of the gut and urinary tract.
- Open Access
- 27 February 2025
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 45 (1) , 148-157
Urobiota and urinary tract infections in liver cirrhosis
The urobiome is being actively studied, diagnostics are being improved and new markers of inflammatory diseases of the urinary tract are being searched for, despite the fact that most microorganisms are unidentified and their functions remain not fully understood. The aim of the study was to study the composition of the urinary tract microbiota (urobiota) in patients with liver cirrhosis, depending on the presence of urinary tract infection. Material and methods. A prospective cohort single-center study was conducted on 48 patients with liver cirrhosis (30 men, 18 women), who, in addition to standard studies, underwent metagenomic sequencing of urine and feces. The average age of the examined patients was 50.5 years, there were 16 and 32 patients with and without urinary tract infection, respectively. High-performance sequencing was performed using the MiSeq genetic analyzer (Illumina, USA) using a protocol based on the analysis of variable regions of the 16s rRNA gene. Data analysis was performed using the Kraken2 algorithm. The significance level of α is assumed to be 0.05. The study is registered in Clinicaltrials.gov (NCT05335213). The results and their discussion. The dominant phylotypes of the urobiota in patients with liver cirrhosis are Proteobacteria, Firmicutes, Actinobacteria, Bacteroidetes, among which Proteobacteria predominate (more than 50 %). The beta diversity of the urinary tract microbiota has significant differences in patients without or with urinary tract infection (p = 0.001). Urinary tract infection increases the density of such taxa in urine as Gammaproteobacteria, including Escherichia, Klebsiella, Acinetobacter, Enterobacter, as well as Bacilli, Synergistia, Deltaproteobacteria, Epsilonproteobacteria, Acidithiobacillia and decreases the density of Prevotella, Clostridioides, Brevundimonas, Delftia, Stenotrophomonas, Streptococcus (p < 0.05). Conclusions. Microbiological identification based on the method of metagenomic sequencing made it possible to identify more than 1,000 types of microorganisms in the urine of patients with liver cirrhosis, including uncultivated ones, and a characteristic bacterial pattern of urinary tract infection, which expands the understanding of the pathogenesis and diagnostic possibilities of urinary tract infections and creates prerequisites for substantiating the directions of microbiota modulation and personalization of patient treatment.
- 27 February 2025
- Published by Institute of Cytology and Genetics, SB RAS in Siberian Scientific Medical Journal
- Vol. 45 (1) , 148-157
Open AccessUrobiota and urinary tract infections in liver cirrhosis
The urobiome is being actively studied, diagnostics are being improved and new markers of inflammatory diseases of the urinary tract are being searched for, despite the fact that most microorganisms are unidentified and their functions remain not fully understood. The aim of the study was to study the composition of the urinary tract microbiota (urobiota) in patients with liver cirrhosis, depending on the presence of urinary tract infection. Material and methods. A prospective cohort single-center study was conducted on 48 patients with liver cirrhosis (30 men, 18 women), who, in addition to standard studies, underwent metagenomic sequencing of urine and feces. The average age of the examined patients was 50.5 years, there were 16 and 32 patients with and without urinary tract infection, respectively. High-performance sequencing was performed using the MiSeq genetic analyzer (Illumina, USA) using a protocol based on the analysis of variable regions of the 16s rRNA gene. Data analysis was performed using the Kraken2 algorithm. The significance level of α is assumed to be 0.05. The study is registered in Clinicaltrials.gov (NCT05335213). The results and their discussion. The dominant phylotypes of the urobiota in patients with liver cirrhosis are Proteobacteria, Firmicutes, Actinobacteria, Bacteroidetes, among which Proteobacteria predominate (more than 50 %). The beta diversity of the urinary tract microbiota has significant differences in patients without or with urinary tract infection (p = 0.001). Urinary tract infection increases the density of such taxa in urine as Gammaproteobacteria, including Escherichia, Klebsiella, Acinetobacter, Enterobacter, as well as Bacilli, Synergistia, Deltaproteobacteria, Epsilonproteobacteria, Acidithiobacillia and decreases the density of Prevotella, Clostridioides, Brevundimonas, Delftia, Stenotrophomonas, Streptococcus (p < 0.05). Conclusions. Microbiological identification based on the method of metagenomic sequencing made it possible to identify more than 1,000 types of microorganisms in the urine of patients with liver cirrhosis, including uncultivated ones, and a characteristic bacterial pattern of urinary tract infection, which expands the understanding of the pathogenesis and diagnostic possibilities of urinary tract infections and creates prerequisites for substantiating the directions of microbiota modulation and personalization of patient treatment.
- 1 December 2024
- Published by Grodno State Medical University in Hepatology and Gastroenterology
- Vol. 8 (2)
CORRELATION OF GUT MICROBIOTA PROFILE AND DECOMPENSATION OF LIVER FUNCTION
Background. There exists a bilateral relationship between the gut microorganisms and the liver, the so-called "gut microbiota-liver" axis. With the progression of liver diseases and a decrease in liver function, there is a change in the qualitative and quantitative composition of the gut microbiota. Objective. To analyze the relationship between the gut microbiota profile and the level of bilirubin, albumin, and prothrombin in patients with liver cirrhosis. Material and methods. A prospective cohort single-center study of 79 hospitalized patients with liver cirrhosis was conducted, which included collection and low-temperature freezing of stool samples. High throughput sequencing was performed with the MiSeq genetic analyzer (Illumina, USA) using a protocol based on the analysis of variable regions of the 16s rRNA gene. The data was analyzed by using the Kraken2 algorithm and by calculating the Spearman correlation coefficient. The significance level of α is assumed to be 0.05. The study is registered in Clinicaltrials.gov (NCT05335213). Results. The gut microbiota in liver cirrhosis and decreased liver function is characterized by an increase in the density of potentially pathogenic taxa such as Proteobacteria, Synergistetes, and a decrease in the taxa of Bacteroidetes, Elusimicrobia, Verrucomicrobia, Aquificae, Candidatus Saccharibacteria, Thermotogae, Ignavibacteriae, which can be attributed to autochthonous. The indices of alpha diversity of the intestinal microbiota (Observed, Shannon, Simpson, Chao1) have no significant differences depending on the level of bilirubin, albumin, and prothrombin. Conclusion. The relationship between the gut microbiota and liver diseases is beyond doubt. With the progression of liver cirrhosis and a decrease in liver function, an increase in the number of pathogenic and a decrease in potentially beneficial taxa of the fecal microbiota is observed.
- 1 December 2024
- Published by Grodno State Medical University in Hepatology and Gastroenterology
- Vol. 8 (2)
CORRELATION OF GUT MICROBIOTA PROFILE AND DECOMPENSATION OF LIVER FUNCTION
Background. There exists a bilateral relationship between the gut microorganisms and the liver, the so-called "gut microbiota-liver" axis. With the progression of liver diseases and a decrease in liver function, there is a change in the qualitative and quantitative composition of the gut microbiota. Objective. To analyze the relationship between the gut microbiota profile and the level of bilirubin, albumin, and prothrombin in patients with liver cirrhosis. Material and methods. A prospective cohort single-center study of 79 hospitalized patients with liver cirrhosis was conducted, which included collection and low-temperature freezing of stool samples. High throughput sequencing was performed with the MiSeq genetic analyzer (Illumina, USA) using a protocol based on the analysis of variable regions of the 16s rRNA gene. The data was analyzed by using the Kraken2 algorithm and by calculating the Spearman correlation coefficient. The significance level of α is assumed to be 0.05. The study is registered in Clinicaltrials.gov (NCT05335213). Results. The gut microbiota in liver cirrhosis and decreased liver function is characterized by an increase in the density of potentially pathogenic taxa such as Proteobacteria, Synergistetes, and a decrease in the taxa of Bacteroidetes, Elusimicrobia, Verrucomicrobia, Aquificae, Candidatus Saccharibacteria, Thermotogae, Ignavibacteriae, which can be attributed to autochthonous. The indices of alpha diversity of the intestinal microbiota (Observed, Shannon, Simpson, Chao1) have no significant differences depending on the level of bilirubin, albumin, and prothrombin. Conclusion. The relationship between the gut microbiota and liver diseases is beyond doubt. With the progression of liver cirrhosis and a decrease in liver function, an increase in the number of pathogenic and a decrease in potentially beneficial taxa of the fecal microbiota is observed.